1. Academic Validation
  2. The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines

The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines

  • Sci Rep. 2022 Sep 16;12(1):15586. doi: 10.1038/s41598-022-19597-4.
Susannah von Hofsten 1 Marianne Hagensen Paulsen 2 Synnøve Norvoll Magnussen 3 Dominik Ausbacher 2 Mathias Kranz 4 Annette Bayer 5 Morten B Strøm 2 Gerd Berge 3
Affiliations

Affiliations

  • 1 Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, 9037, Tromsø, Norway. susannah.hofsten@uit.no.
  • 2 Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, 9037, Tromsø, Norway.
  • 3 Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, 9037, Tromsø, Norway.
  • 4 PET Imaging Center Tromsø, University Hospital of North Norway, 9019, Tromsø, Norway.
  • 5 Department of Chemistry, UiT The Arctic University of Norway, 9037, Tromsø, Norway.
Abstract

Bioprospecting contributes to the discovery of new molecules with Anticancer properties. Compounds with cytolytic activity and the ability to induce immunogenic cell death can be administered as intratumoral injections with the aim to activate anti-tumor immune responses by causing the release of tumor antigens as well as damage-associated molecular patterns (DAMPs) from dying Cancer cells. In the present study, we report the cytolytic and DAMP-releasing effects of a new natural product mimic termed MPM-1 that was inspired by the marine Eusynstyelamides. We found that MPM-1 rapidly killed Cancer cells in vitro by inducing a necrosis-like death, which was accompanied by lysosomal swelling and perturbation of Autophagy in HSC-3 (human oral squamous cell carcinoma) cells. MPM-1 also induced release of the DAMPs adenosine triphosphate (ATP) and high mobility group box 1 (HMGB1) from Ramos (B-cell lymphoma) and HSC-3 cells, as well as cell surface expression of calreticulin in HSC-3 cells. This indicates that MPM-1 has the ability to induce immunogenic cell death, further suggesting that it may have potential as a novel Anticancer compound.

Figures
Products